SC
VCYT icon

Schubert & Co’s Veracyte VCYT Stock Holding History

Schubert & Co’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8
Closed -$179 – 1459
2023
Q1 		$179 Buy
+8
New +$193 ﹤0.01% 1560
2022
Q2 		– Sell
-5
Closed – – 1608
2022
Q1 		$0 Buy
5
+4
+400% +$114 ﹤0.01% 1357
2021
Q4 		$0 Buy
+1
New +$44 ﹤0.01% 1306

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Schubert & Co's VCYT Position: Q2 2023 in Review

Schubert & Co sold out of Veracyte (VCYT) in Q2 2023, closing a stake of 8 shares — an estimated $179 sold.

Schubert & Co first reported a position in VCYT in Q4 2021 and held it in 3 quarters. The position peaked at $179 in Q1 2023. 232 funds tracked by Wall St. Rank hold VCYT as of Q2 2023.

  • Schubert & Co reported no remaining Veracyte position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 8 Veracyte shares in Q2 2023, an estimated $179.
  • Schubert & Co first reported a position in Veracyte in Q4 2021 and held it in 3 quarters.
  • Schubert & Co's Veracyte position peaked at $179 in Q1 2023.
  • 232 funds tracked by Wall St. Rank held Veracyte as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.